Association of hormone replacement therapy with risk of parkinson’s disease in post-menopausal women: a meta-analysis for cohort study

  • At: 2017 FIP Congress in Seoul (South Korea)
  • Type: Poster
  • By: HO, Chen-Pei (Hualien Tzu Chi Medical Center / Tzu Chi University, pharmacy, Hualien, China Taiwan)
  • Co-author(s): Chen-Pei Ho: Department of Pharmacy, Buddhist Tzu Chi General Hospital, Hualien, Taiwan, Province of China;Institute of Medical Sciences, College of Medicine, Tzu Chi University, Hualien, Taiwan, Province of China
    Tony Jer-Fu Lee: Institute of Medical Sciences, College of Medicine, Tzu Chi University, Hualien, Taiwan, Province of China;Department of Medical Research, Buddhist Tzu Chi General Hospital, Hualien, Taiwan, Province of China;Department of Life Sciences, College of Life Sciences, Tzu Chi University, Hualien, Taiwan, Province of China;Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL, United States
  • Abstract:

    Background

    Some evidences indicated that hormone replacement therapy (HRT) was associated with a significantly lower risk of Parkinson’s disease.

    Purpose

    The purpose of this meta-analysis is to evaluate the association between HRT and lowered risk of Parkinson’s disease in post-menopausal women.

    Methods

    The information is obtained mainly from the..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login